Matches in SemOpenAlex for { <https://semopenalex.org/work/W2983176028> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2983176028 abstract "Abstract Neurofibromatosis type 2 (NF2) is a tumor predisposition syndrome characterized by the development of schwannomas, especially bilateral vestibular schwannomas (VS), and meningiomas. Heterozygous pathogenic variants in the NF2 gene are known to cause NF2, whereby somatic mosaicism is present in ~25% of simplex patients. In schwannomatosis, a disorder phenotypically similar to NF2, heterozygous SMARCB1 or LZTR1 variants may be causative. Recently, bevacizumab has shown efficiency as therapy for VS in some NF2 patients. We report on a thirty-three-year-old patient with bilateral VS, fourteen additional schwannomas and one intracranial meningioma. Next generation sequencing using a cancer gene panel and Sanger sequencing of LZTR1 on blood and oral mucosa DNA revealed no pathogenic variants in NF2, SMARCB1 or LZTR1. Sanger sequencing on DNA from three schwannomas identified the known NF2 nonsense variant c.784C >T;p.(R262*) (NM_000268.3, GRCh37/hg19) in all tumors, leading to the diagnosis of somatic NF2 mosaicism. Because of hearing impairment and tumor progression the patient underwent an off-label therapy with 5mg/kg bevacizumab. To determine treatment response, we evaluated MRI scans from five pre-therapeutic and two therapeutic years as well as pure-tone audiometry. After 25 months of treatment, (i) the pure-tone average improved by 11.2 dB indicating a hearing benefit, (ii) four of seven non-vestibular schwannomas showed a volume reduction of ≥ 20%, (iii) the volume of three of seven schwannomas stabilized, and (iv) the growth rate of the meningioma decreased. In conclusion, in a patient with somatic NF2 mosaicism, an off-label therapy with bevacizumab was efficient with respect to hearing improvement and tumor shrinkage in over half of non-vestibular schwannomas over a period of two years." @default.
- W2983176028 created "2019-11-22" @default.
- W2983176028 creator A5003343670 @default.
- W2983176028 creator A5005501545 @default.
- W2983176028 creator A5010036887 @default.
- W2983176028 creator A5012985037 @default.
- W2983176028 creator A5029164164 @default.
- W2983176028 creator A5030896666 @default.
- W2983176028 creator A5044208679 @default.
- W2983176028 creator A5050846374 @default.
- W2983176028 creator A5052395678 @default.
- W2983176028 creator A5064880086 @default.
- W2983176028 creator A5072724019 @default.
- W2983176028 date "2019-11-01" @default.
- W2983176028 modified "2023-09-23" @default.
- W2983176028 title "INNV-06. TREATMENT RESPONSE TO BEVACIZUMAB OVER TWO YEARS IN A PATIENT WITH GENETICALLY PROVEN SOMATIC NEUROFIBROMATOSIS TYPE 2 MOSAICISM" @default.
- W2983176028 doi "https://doi.org/10.1093/neuonc/noz175.549" @default.
- W2983176028 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6847289" @default.
- W2983176028 hasPublicationYear "2019" @default.
- W2983176028 type Work @default.
- W2983176028 sameAs 2983176028 @default.
- W2983176028 citedByCount "0" @default.
- W2983176028 crossrefType "journal-article" @default.
- W2983176028 hasAuthorship W2983176028A5003343670 @default.
- W2983176028 hasAuthorship W2983176028A5005501545 @default.
- W2983176028 hasAuthorship W2983176028A5010036887 @default.
- W2983176028 hasAuthorship W2983176028A5012985037 @default.
- W2983176028 hasAuthorship W2983176028A5029164164 @default.
- W2983176028 hasAuthorship W2983176028A5030896666 @default.
- W2983176028 hasAuthorship W2983176028A5044208679 @default.
- W2983176028 hasAuthorship W2983176028A5050846374 @default.
- W2983176028 hasAuthorship W2983176028A5052395678 @default.
- W2983176028 hasAuthorship W2983176028A5064880086 @default.
- W2983176028 hasAuthorship W2983176028A5072724019 @default.
- W2983176028 hasBestOaLocation W29831760281 @default.
- W2983176028 hasConcept C104317684 @default.
- W2983176028 hasConcept C126322002 @default.
- W2983176028 hasConcept C142724271 @default.
- W2983176028 hasConcept C143998085 @default.
- W2983176028 hasConcept C167227067 @default.
- W2983176028 hasConcept C177450382 @default.
- W2983176028 hasConcept C2776694085 @default.
- W2983176028 hasConcept C2777802072 @default.
- W2983176028 hasConcept C2778679214 @default.
- W2983176028 hasConcept C2779160599 @default.
- W2983176028 hasConcept C2781447767 @default.
- W2983176028 hasConcept C51679486 @default.
- W2983176028 hasConcept C54355233 @default.
- W2983176028 hasConcept C71924100 @default.
- W2983176028 hasConcept C76818968 @default.
- W2983176028 hasConcept C83640560 @default.
- W2983176028 hasConcept C86803240 @default.
- W2983176028 hasConceptScore W2983176028C104317684 @default.
- W2983176028 hasConceptScore W2983176028C126322002 @default.
- W2983176028 hasConceptScore W2983176028C142724271 @default.
- W2983176028 hasConceptScore W2983176028C143998085 @default.
- W2983176028 hasConceptScore W2983176028C167227067 @default.
- W2983176028 hasConceptScore W2983176028C177450382 @default.
- W2983176028 hasConceptScore W2983176028C2776694085 @default.
- W2983176028 hasConceptScore W2983176028C2777802072 @default.
- W2983176028 hasConceptScore W2983176028C2778679214 @default.
- W2983176028 hasConceptScore W2983176028C2779160599 @default.
- W2983176028 hasConceptScore W2983176028C2781447767 @default.
- W2983176028 hasConceptScore W2983176028C51679486 @default.
- W2983176028 hasConceptScore W2983176028C54355233 @default.
- W2983176028 hasConceptScore W2983176028C71924100 @default.
- W2983176028 hasConceptScore W2983176028C76818968 @default.
- W2983176028 hasConceptScore W2983176028C83640560 @default.
- W2983176028 hasConceptScore W2983176028C86803240 @default.
- W2983176028 hasLocation W29831760281 @default.
- W2983176028 hasLocation W29831760282 @default.
- W2983176028 hasOpenAccess W2983176028 @default.
- W2983176028 hasPrimaryLocation W29831760281 @default.
- W2983176028 hasRelatedWork W1696812633 @default.
- W2983176028 hasRelatedWork W2086398310 @default.
- W2983176028 hasRelatedWork W2129451356 @default.
- W2983176028 hasRelatedWork W2272820807 @default.
- W2983176028 hasRelatedWork W2281367559 @default.
- W2983176028 hasRelatedWork W2303796269 @default.
- W2983176028 hasRelatedWork W2607935491 @default.
- W2983176028 hasRelatedWork W2811010543 @default.
- W2983176028 hasRelatedWork W2953526441 @default.
- W2983176028 hasRelatedWork W3011149587 @default.
- W2983176028 hasRelatedWork W3014380346 @default.
- W2983176028 hasRelatedWork W3016595792 @default.
- W2983176028 hasRelatedWork W3045687439 @default.
- W2983176028 hasRelatedWork W3109879696 @default.
- W2983176028 hasRelatedWork W3123823948 @default.
- W2983176028 hasRelatedWork W3130304666 @default.
- W2983176028 hasRelatedWork W3159968066 @default.
- W2983176028 hasRelatedWork W3202958151 @default.
- W2983176028 hasRelatedWork W3204192470 @default.
- W2983176028 hasRelatedWork W3206675578 @default.
- W2983176028 isParatext "false" @default.
- W2983176028 isRetracted "false" @default.
- W2983176028 magId "2983176028" @default.
- W2983176028 workType "article" @default.